Related Experiment Video
Updated: Jan 29, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF7
Seyedeh Mahya Shariat Razavi1, Mohammad Mahdi Forghanifard2, Dor Mohammad Kordi-Tamandani3
1Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran; Medical Genetics Research Center, Faculty of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Tumor relapse is the main cause of breast cancer related deaths and metastasis due to epithelial-mesenchymal transition (EMT) having a critical role in this process. MAML1 is the main co activator of NOTCH signaling pathway and its role in EMT remains unknown. In this study, this role was evaluated through overexpression and knockdown study of MAML1 in MCF7 and MDA-MB-231 cells. MAML1 overexpression up regulated the epithelial and down regulated the mesenchymal markers. In addition, MAML1 silencing decreased epithelial and increased mesenchymal markers. Notch inhibition using γ-secretase inhibitor resulted in increased E-cadherin expression. MAML1 ectopic expression, further increased E-cadherin expression with inhibition of NOTCH signaling. Wound healing assay showed that MAML1 overexpression decreases the rate of migration, while MAML1 silencing increases this rate significantly. In conclusion, our data indicated that MAML1 negatively regulates EMT markers expression in breast cancer cells.
Insights
Mastermind-like protein 1 (MAML1) negatively regulates epithelial-mesenchymal transition (EMT) in breast cancer cells, impacting tumor metastasis and relapse. This study reveals MAML1
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tumor relapse and metastasis are primary causes of breast cancer mortality.
- Epithelial-mesenchymal transition (EMT) is a critical process driving metastasis.
- The role of Mastermind-like protein 1 (MAML1), a NOTCH co-activator, in EMT is not well understood.
Purpose of the Study:
- To investigate the role of MAML1 in regulating EMT in breast cancer cells.
- To determine how MAML1 expression affects epithelial and mesenchymal markers.
- To assess the impact of MAML1 on breast cancer cell migration.
Main Methods:
- Overexpression and knockdown of MAML1 in MCF7 and MDA-MB-231 breast cancer cell lines.
- Analysis of epithelial and mesenchymal markers.
- NOTCH signaling inhibition using a gamma-secretase inhibitor.
- Wound healing assays to evaluate cell migration.
Main Results:
- MAML1 overexpression upregulated epithelial markers and downregulated mesenchymal markers.
- MAML1 silencing decreased epithelial markers and increased mesenchymal markers.
- MAML1 overexpression, with NOTCH inhibition, further increased E-cadherin expression and decreased cell migration.
- MAML1 silencing significantly increased cell migration.
Conclusions:
- MAML1 acts as a negative regulator of EMT in breast cancer cells.
- Modulating MAML1 expression influences key markers of EMT and cell motility.
- MAML1's role in regulating EMT suggests potential therapeutic implications for breast cancer metastasis.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Regulation of Expression at Multiple Steps
Constitutive and Regulated Gene Expression
Cell Specific Gene Expression

